Faisal Sanai

10PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineCancer geneticsPredictive and prognostic markersPacific Peoples cultural determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 12, 2025
Transarterial Chemoembolization Outperforms Radioembolization in Early- and Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Faisal M Sanai, Adnan Alzanbagi, Mohammed Arabi

|May 24, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority Agenda.

|Jan 03, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021.

Chutian Wu, Giovanni Targher, Christopher D Byrne

|Jun 27, 2024
Nivolumab as Second-Line Therapy Improves Survival in Patients with Unresectable Hepatocellular Carcinoma.

Faisal M Sanai, Hassan O Odah, Kanan Alshammari

|Apr 16, 2024
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.

Saleh A Alqahtani, Yusuf Yilmaz, Mohamed El-Kassas

|Mar 28, 2024
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.

Wesam Bahitham, Siraj Alghamdi, Ibrahim Omer

Pageof 2

Frequent Collaborators

3 joint publications

Saleh A Alqahtani

2 joint publications

Zobair M Younossi

2 joint publications

Khalid I Bzeizi

2 joint publications

Mohamed El-Kassas